Cannaport and HAPA pharm sign exclusive cooperation agreement

[Press release] Cannaport and HAPA pharm sign exclusive cooperation agreement concerning the supply of cannabis flowers and extracts containing cannabinoids to the DACH market Hamburg, 15.03.2022: The Hamburg based distribution and wholesaler company Cannaport GmbH and the internationally operating HAPA pharm GmbH from Dortmund have agreed to an extensive strategic cooperation concerning the supply of …

Cannaport and HAPA pharm sign exclusive cooperation agreement Read More »

HAPA pharm receives GMP certification

HAPA pharm (“HAPA” or the “Company”) operates production facilities in North Macedonia to grow and process medical cannabis for the sale of pharmaceutical cannabis flos and extracts. On May 1st 2020, the Company has successfully received GMP (Good Manufacturing Practice) approval for both facilities.This milestone demonstrates HAPA’s commitment towards stringent quality assurance on premises and …

HAPA pharm receives GMP certification Read More »

COVID-19: A message to our customers, suppliers and partners

HAPA pharm is actively responding to the situation of coronavirus (COVID-19) by following the recommendations of local and international authorities. We have proactively implemented measures that give priority to the health and safety of our employees, customers and partners, including restricted business travel and access to our sites, improved safety and hygiene, and the ability …

COVID-19: A message to our customers, suppliers and partners Read More »

Pressrelease November 2018

Käfer Dachgarten-Restaurant im Deutschen Bundestag Demnächst steht in Deutschland mit dem HAPA medical Vollspektrum Cannabis Extrakt THC2.5 CBD2.5 (Lösung) ein neues Extrakt zur Herstellung eines Rezepturarzneimittels aus medizinischem Cannabis zur Verfügung. Daher laden wir Journalisten der medizinischen Fachpresse herzlich zur Launch-Fachpresseveranstaltung ein: Aus Cannabis wird Medizin – Neues orales Cannabis Extrakt THC2,5:CBD2,5 (Lösung) Montag, 12. …

Pressrelease November 2018 Read More »

We grow innovation

HAPA medical partners with Australian Zelda Therapeutics for the advancement of clinical cannabinoid research While experimental studies have already unveiled many mechanisms of action for a wide array of cannabinoids, there is still a lack of proper clinical trials which hinders the practical therapeutic application of cannabinoid medicine. Our partner Zelda Therapeutics brings together some …

We grow innovation Read More »

Scroll to Top


This content is currently only available in German.

Lieber Arzt, Lieber Apotheker,

im Passwort-geschützten Bereich unserer Website haben wir zahlreiche wertvolle Artikel für Sie zur Verfügung gestellt. Unter anderem finden Sie Informationen zu folgenden Themen: 

  • Verschreibung & Erstattung, GOP
  • Antragstellung Krankenkasse (was Sie Ihren Patienten unbedingt mitteilen sollen)
  • Produktübersicht
  • Dosisfindung